📰 Study Previously Difficult News
Study Previously Difficult News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Study Previously Difficult. Real-time updates on events, politics, business and more.
April 27, 2022
Patent applications cover three types of cellular therapies and related technologies
April 27, 2022
NASDAQ Biotech AVCO makes Big Moves Filing 16 Patent Applications, Co-Inventors are leading Universities & Cellular Therapy Developers; Avalon Globocare $AVCO
April 8, 2022
$AVCO a Leading global developer of cell-based Technologies & Therapeutics be next? Avalon Globocare Corp. (NASDAQ: AVCO)
January 15, 2022
AVCO’s Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
December 24, 2021
AVCO’s Chairman Converts $3.0 million of debt into common stock at $1.25 per share showing continued confidence and support of the business.
December 13, 2021
This new approach is advancing our capabilities in designing novel immuno-oncology and cellular
October 22, 2021
A study of the new technology was featured in the September 2021 issue of Membranes, an international, peer-reviewed journal.